132 related articles for article (PubMed ID: 481003)
1. [Osteogenesis imperfecta tarda: the value of the determination of the urinary excretion of hydroxyprolyne (author's transl)].
Rico Lenza H; del Río Vázquez A; Serrano Garijo P; Espinós Pérez D
Med Clin (Barc); 1979 Jun; 73(2):55-8. PubMed ID: 481003
[No Abstract] [Full Text] [Related]
2. [Hydroxyprolinuria, index of severity in osteogenesis imperfecta tarda].
Rico Lenza H; Del Rio Vazquez A; Espinos Perez D
Nouv Presse Med; 1978 Dec; 7(43):3941. PubMed ID: 733559
[No Abstract] [Full Text] [Related]
3. [A contribution to the recording and study of the disease pattern of osteogenesis imperfecta tarda (author's transl)].
Matzen KA; Werner KC
Z Orthop Ihre Grenzgeb; 1979 Feb; 117(1):21-30. PubMed ID: 425623
[TBL] [Abstract][Full Text] [Related]
4. [Hydroxyproline elimination in urine in osteogenesis imperfecta].
Langness U; Behnke H
Klin Wochenschr; 1966 Nov; 44(22):1294-7. PubMed ID: 5991118
[No Abstract] [Full Text] [Related]
5. [Osteogenesis imperfecta cystica (Fairbank)--a special form of osteogenesis imperfecta congenita (Vrolik) (author's transl)].
Clemens D; Benz HJ
Rofo; 1979 Jul; 131(1):72-7. PubMed ID: 157936
[TBL] [Abstract][Full Text] [Related]
6. [Does the determination of acid mucopolysaccharides and hydroxyproline contribute to the differential diagnosis of fibrous dysplasia (Jaffé-Lichtenstein) and osteogenesis imperfecta congenita?].
Beck O; Schramm G; Kyselka R
Beitr Orthop Traumatol; 1972 Dec; 19(12):740-2. PubMed ID: 4265462
[No Abstract] [Full Text] [Related]
7. [Hydroxyproline excretion as an index for the evaluation of metabolic bone changes].
Mühlbach R
Beitr Orthop Traumatol; 1966 Oct; 13(10):606-8. PubMed ID: 5977397
[No Abstract] [Full Text] [Related]
8. [Osteogenesis imperfecta (author's transl)].
Zergollern L; Depeder Z; Stakić A; Rezić P
Lijec Vjesn; 1976 Aug; 98(8):412-8. PubMed ID: 1004092
[No Abstract] [Full Text] [Related]
9. [Collagen metabolism in osteogenesis imperfecta].
Balaba TIa; Furtseva LN; Nefed'eva NN
Vopr Med Khim; 1974; 20(5):471-6. PubMed ID: 4456796
[No Abstract] [Full Text] [Related]
10. Effect of long-term calcitonin therapy on the clinical course of osteogenesis imperfecta.
Rosenberg E; Lang R; Boisseau V; Rojanasathit S; Avioli LV
J Clin Endocrinol Metab; 1977 Feb; 44(2):346-55. PubMed ID: 557059
[TBL] [Abstract][Full Text] [Related]
11. [Basal angle in pathological cases (author's transl)].
Slomic AM; Bernier JP; Morissette J
J Radiol Electrol Med Nucl; 1978 Dec; 59(12):711-4. PubMed ID: 106110
[No Abstract] [Full Text] [Related]
12. [Urinary hydroxyproline excretion in generalized bone diseases].
Czitober H; Raab W
Wien Z Inn Med; 1967; 48(10):401-8. PubMed ID: 5620579
[No Abstract] [Full Text] [Related]
13. [Study of urinary hydroxyproline in osteopathies].
Kocher P
Pathol Biol; 1966 Nov; 14(21):1020-39. PubMed ID: 5339820
[No Abstract] [Full Text] [Related]
14. [Urinary excretion of hydroxyproline during the healing period of bone fractures (author's transl)].
Drommer R
Z Orthop Ihre Grenzgeb; 1979 Feb; 117(1):77-82. PubMed ID: 425628
[TBL] [Abstract][Full Text] [Related]
15. [Clinical picture and genetics of osteogenesis imperfecta].
Langness U; Behnke H
Dtsch Med Wochenschr; 1970 Jan; 95(5):209-12 passim. PubMed ID: 5410905
[No Abstract] [Full Text] [Related]
16. ["In utero" diagnosis of congenital fragilitas ossium (osteogenesis imperfecta) (author's transl)].
Berzine J; Cheniti T; Bel Aicha N; Kamoun A; Ben Amor MS
J Gynecol Obstet Biol Reprod (Paris); 1979; 8(8):735-6. PubMed ID: 553932
[TBL] [Abstract][Full Text] [Related]
17. [Pseudosarcomatous hyperostosis in osteogenesis imperfecta (author's transl)].
Kolár J; Vyhnánek L
Cesk Radiol; 1976 Jan; 30(1):20-6. PubMed ID: 1253322
[No Abstract] [Full Text] [Related]
18. Current aspects of the surgical treatment of osteogenesis imperfecta.
Williams PF; Cole WH; Bailey RW; Dubow HI; Solomons CC; Millar EA
Clin Orthop Relat Res; 1973 Oct; (96):288-98. PubMed ID: 4749825
[No Abstract] [Full Text] [Related]
19. A "new" bone dysplasia with autosomal recessive inheritance.
Temtamy SA; Meligy RE; Osman NM; Meguid MS; Salem S
Birth Defects Orig Artic Ser; 1974; 10(10):165-70. PubMed ID: 4462629
[No Abstract] [Full Text] [Related]
20. [Treatment of osteogenesis imperfecta with (+)-catechin (author's transl)].
Stöss H; Pesch HJ; Spranger J
Dtsch Med Wochenschr; 1979 Dec; 104(50):1774, 1777-8. PubMed ID: 510214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
